$93.15
-0.20-0.21%
Pre-Market: 6:02 AM EDT
Merck & Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Merck & Co using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-04 | $1.72 | $1.68 | 2.38 % |
Q3 | 2024-10-31 | $1.57 | $1.51 | 3.97 % |
Q2 | 2024-07-30 | $2.28 | $2.15 | 6.05 % |
Q1 | 2024-04-25 | $2.07 | $1.87 | 10.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-04 | $15.62B | $15.51B | 0.74 % |
Q3 | 2024-10-31 | $16.66B | $16.47B | 1.14 % |
Q2 | 2024-07-30 | $16.11B | $15.84B | 1.72 % |
Q1 | 2024-04-25 | $15.78B | $15.20B | 3.78 % |
Merck & Co (MRK) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 4, 2025 for Q4.
The Actual EPS was $1.72, which beat the estimate of $1.68.
The Actual Revenue was $15.6B, which beat the estimate of $15.5B.
Browse earnings estimates, EPS, and revenue on all stocks.